Almirall SA - Company Profile
Powered by 
All the sales intelligence you need on Almirall SA in one solution.
- Save hours of research time with a comprehensive
Sales Intelligence Solution.
- Understand how Almirall SA fits into your total
addressable market and Ideal Customer Profile.
- Gain competitive edge with triggers that tell you
when and how to engage with Almirall SA.
Get in touch about GlobalData Company reports
Contact the team or request a demo to find out how our data can drive your business forward
Almirall SA (Almirall) is a pharmaceutical company. The company's main activities include the development, production, and marketing of medical solutions for dermatological conditions such as psoriasis, atopic dermatitis, acne, and actinic keratosis. It also develops and markets general medicine and OTCs related to the central nervous, cardiovascular, dermatology, gastrointestinal, and musculoskeletal systems. Almirall collaborates with strategic partners and operates through a network of local sales networks, licensees, third-party manufacturing, and intermediaries to distribute its products. The company's products are used by healthcare professionals to treat patients through brands such as Ilumetri, Wynzora, and Skilarence. The company has business presence in Europe, the Middle East, the Americas, Asia, and Africa. Almirall is headquartered in Barcelona, Spain.
Headquarters
Spain
Address
Ronda General Mitre, 151, Barcelona, Barcelona , 08022
Website
www.almirall.com
Telephone
34 932 913000
No of Employees
2,108
Industry
Pharmaceuticals and Healthcare
Ticker Symbol & Exchange
ALM (MCE)
Revenue (2024)
$1.3B
12.4%
(2024 vs 2023)
EPS
XYZ
Net Income (2024)
XYZ
354.9%
(2024 vs 2023)
Market Cap*
$2.9B
Net Profit Margin (2024)
XYZ
304.9%
(2024 vs 2023)
* As of and is in US$
Almirall SA premium industry data and analytics
Products and Services
| Products | Brands |
|---|---|
| Generic Medicines | Airtal |
| Dermatology Products | Almax |
| Over-the-Counter Products | Actikerall |
| XYZ | XYZ |
| XYZ | XYZ |
| XYZ | XYZ |
History
History section provides information on new products, mergers, acquisitions, expansions, approvals, and many more key events.
| Year | Event | Description |
|---|---|---|
| 2026 | Contracts/Agreements | In April, the company expanded its partnership with the Barcelona Supercomputing Center – Centro Nacional de Supercomputacion to enhance research and development in medical dermatology. |
| 2026 | Regulatory Approval | In January, the company received approval from China’s NMPA for Seysara to treat moderate-to-severe acne in patients aged nine and older. |
| 2025 | Contracts/Agreements | In August, the company expanded its partnership with Absci Corporation to deliver AI-designed, functional antibody leads against a difficult-to-drug target. |
Competitor Comparison
| Key Parameters | Almirall SA | ALK-Abello AS | Laboratorios Farmaceuticos Rovi SA | Esteve Pharmaceuticals SA | Faes Farma SA |
|---|---|---|---|---|---|
| Headquarters | Spain | Denmark | Spain | Spain | Spain |
| City | Barcelona | Hoersholm | Madrid | Barcelona | Leioa |
| State/Province | Barcelona | - | Madrid | Barcelona | Vizcaya |
| No. of Employees | 2,108 | 2,759 | 2,232 | 2,059 | 2,671 |
| Entity Type | Public | Public | Public | Private | Public |
Key Financial Charts
Sales Growth
Net Income Growth
Executives
| Name | Position | Board | Since | Age |
|---|---|---|---|---|
| Carlos Gallardo Pique | Chairman; Chief Executive Officer | Executive Board | 2023 | - |
| Jon U. Garay | Chief Financial Officer | Senior Management | - | - |
| Volker Koscielny | Chief Medical Officer | Senior Management | - | - |
| Karl Ziegelbauer | Chief Scientific Officer | Senior Management | 2021 | - |
| Eloi Crespo Cervera | Chief Industrial Operations Officer | Senior Management | 2018 | - |
| Non Dignissim Eros | Proin vel | Convallis | 2026 | XY |
| Non Dignissim Eros | Proin vel | Convallis | 2026 | XY |
| Non Dignissim Eros | Proin vel | Convallis | 2026 | XY |
Still looking?
Have you found what you were looking for? From start-ups to market leaders, uncover what they do and how they do it.
Explorer
Access more premium companies when you subscribe to Explorer